{
    "data": [
        {
            "id": "67a220e29d57a90001d4dda2",
            "title": "This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/4-Stocks-You-Need-To-Buy-Now-for-Consist.jpeg",
            "link": "https://www.benzinga.com/25/02/43463074/this-expand-energy-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday",
            "pub_date": "2025-02-04 22:15:02",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a220eb9d57a90001d4ddb5",
            "title": "If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg",
            "link": "https://www.benzinga.com/insights/news/25/02/43463093/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-this-much-today",
            "pub_date": "2025-02-04 22:15:11",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a21f769d57a90001d4dc50",
            "title": "Cosmetics Major Estee Lauder Q2 Earnings: Sales Slump, Restructuring Deepens, But CEO Bets On &#39;Beauty Reimagined&#39;",
            "description": "Shares of Estee Lauder Companies fell following the company&#39;s FY25 earnings report. The company plans a major restructuring under its Profit Recovery and Growth Plan, aiming for a leaner, more agile business. ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/Bangkok--Thailand---November-20--2020--E.jpeg",
            "link": "https://www.benzinga.com/news/earnings/25/02/43462736/cosmetics-major-estee-lauder-q2-earnings-sales-slump-restructuring-deepens-but-ceo-bets-on-beauty-reimagined",
            "pub_date": "2025-02-04 22:08:58",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a21fba9d57a90001d4dcfb",
            "title": "Insights into DSV Q4 Earnings",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg",
            "link": "https://www.benzinga.com/insights/earnings/25/02/43462907/insights-into-dsv-q4-earnings",
            "pub_date": "2025-02-04 22:10:06",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a21d999d57a90001d4db82",
            "title": "Forecasting The Future: 6 Analyst Projections For Twist Bioscience",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg",
            "link": "https://www.benzinga.com/insights/analyst-ratings/25/02/43462532/forecasting-the-future-6-analyst-projections-for-twist-bioscience",
            "pub_date": "2025-02-04 22:01:01",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}